Eton Pharmaceuticals, Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

17.93

-0.29 (-1.59%)

At close: Feb 20, 2026, 4:00 PM EST

17.98

+0.05 (0.28%)

After-hours: Feb 20, 2026, 7:34 PM EST

Eton Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	70.32	39.01	31.64	21.25	21.83	0.04
Revenue Growth (YoY)	102.77%	23.29%	48.90%	-2.66%	55879.49%	-95.93%
Cost of Revenue	30.53	15.6	10.58	6.93	2.83	0.44
Gross Profit	39.79	23.41	21.06	14.32	19.01	-0.4
Selling, General & Admin	33.27	22.34	18.93	18.58	14.27	12.67
Research & Development	5.11	3.26	3.32	4	6.23	14.05
Operating Expenses	38.38	25.59	22.25	22.58	20.5	26.71
Operating Income	1.41	-2.18	-1.19	-8.26	-1.5	-27.11
Interest Expense	-4.91	-2.01	-1.06	-0.96	-1.04	-0.88
Interest & Investment Income	1.1	0.79	1.56	0.19	0.04	0.03
EBT Excluding Unusual Items	-2.4	-3.39	-0.69	-9.02	-2.5	-27.97
Merger & Restructuring Charges	-4.09	-0.42	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	0.18	-
Other Unusual Items	-	-	-	-	0.37	-
Pretax Income	-6.48	-3.81	-0.69	-9.02	-1.96	-27.97
Income Tax Expense	0.2	0.02	0.25	-	-	-
Net Income	-6.68	-3.82	-0.94	-9.02	-1.96	-27.97
Net Income to Common	-6.68	-3.82	-0.94	-9.02	-1.96	-27.97
Shares Outstanding (Basic)	27	26	26	25	25	21
Shares Outstanding (Diluted)	27	26	26	25	25	21
Shares Change (YoY)	3.52%	0.97%	1.99%	-0.24%	19.98%	18.30%
EPS (Basic)	-0.25	-0.15	-0.04	-0.36	-0.08	-1.33
EPS (Diluted)	-0.26	-0.15	-0.04	-0.36	-0.08	-1.33
Free Cash Flow	21.01	0.94	6.82	4.78	-4.73	-22.4
Free Cash Flow Per Share	0.79	0.04	0.27	0.19	-0.19	-1.07
Gross Margin	56.59%	60.01%	66.56%	67.38%	87.05%	-
Operating Margin	2.00%	-5.59%	-3.77%	-38.87%	-6.85%	-69515.39%
Profit Margin	-9.50%	-9.80%	-2.96%	-42.45%	-8.96%	-71717.95%
Free Cash Flow Margin	29.89%	2.42%	21.54%	22.51%	-21.66%	-57425.64%
EBITDA	4.72	-1.11	-0.36	-6.55	-1.12	-26.59
EBITDA Margin	6.71%	-2.83%	-1.13%	-30.81%	-5.13%	-
D&A For EBITDA	3.31	1.08	0.83	1.71	0.37	0.52
EBIT	1.41	-2.18	-1.19	-8.26	-1.5	-27.11
EBIT Margin	2.00%	-5.59%	-3.77%	-38.87%	-6.85%	-
Revenue as Reported	70.32	39.01	31.64	21.25	21.83	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q